In blood and tumors of subcutaneously transplanted tumor mice and CAC mice, the Th1/Th2 ratio (shown by IFN-γ/IL-4) was decreased after romidepsin treatment, which could be reversed when combined with anti-PD-1 treatment (Fig. 6a). This evidence concerns the gene IL4 and neoplasm.